Phase I Study to Determine the Safety and Tolerability of the Oral Microtubule Destabilizer BAL 101553 in Combination with Standard Radiation in Patients with MGMT Promoter Unmethylated Newly Diagnosed Glioblastoma

Grant

Date/time Interval

  • September 24, 2017 - April 30, 2021
  • Total Award Amount

  • 18000.00
  • Direct Costs

  • 9270.00
  • Sponsor Award Id

  • ABTC1601
  • Contributor

  • Hassan Fathallah-Shaykh M.D., Ph.D.   Investigator  
  • Louis Nabors M.D.   Principal Investigator  
  • Xiaosi Han   Investigator